第2回 癌的分子标靶
2008年3月26～28日

1. DEVELOPING MICRORNA TOOLS INTO TISSUE-SPECIFIC DIAGNOSTIC MARKERS为了组织特异性诊断标靶之微(Micro)RNA工具开发（经路解析之共同议程）
2. microRNA DYSFUNCTION REGULATION微RNA的机能障害相关之规范（经路解析之共同议程）
3. 分子诊断的案例学习（分子诊断和研究开发的风险降低之共同议程）
4. 毒性经路（经路解析、临床前开发、药剂安全性动向之共同议程）
5. 治疗主题：癌和干细胞（干细胞会议之共同议程）
6. 癌的分子诊断（分子诊断之共同议程）

HIGHLIGHTS THIS YEAR

• TISSUE-SPECIFIC microRNA DIAGNOSTIC MARKERS

• NON CODING RNAs IN CANCER PREDISPOSITION AND TUMOR DEVELOPMENT

• microRNAs IN CHRONIC MYELOID LEUKEMIA

• RESPONSE PREDICTION IN ONCOLOGY

• TOXICOLOGY STRATEGY SPECIFIC TO

• NOVEL ONCOLOGY TARGETS

• MOLECULAR MARKERS OF PROSTATE CANCER STEM CELLS

• POTENTIAL FOR IN SITU PROXIMITY LIGATION DIAGNOSTICS

Regulation of Diagnostic Tests Steven I. Gutman, M.D., Director, Office of In Vitro Diagnostic Device Evaluation and Safety, Food & Drug Administration - Speaker Biography

FEATURED SPEAKERS

Andrea Califano, Ph.D., Professor and Director, Genome Center Bioinformatics, Columbia University

 

 

 

Pablo Landgraf, M.D., Ph.D., Group Leader, Department of Pediatric Oncology, Hematology and Clinical Immunology, Childrens Hospital of the Heinrich-Heine University Dsseldorf

 

 

George A. Calin, M.D., Ph.D., Associate Professor, Department of Experimental Therapeutics, University of Texas, MD Anderson Cancer Centre

 

 

 

Isidore Rigoutsos, Ph.D., Manager, Bioinformatics & Pattern Discovery Group, Computational Biology Center, IBM Thomas J. Watson Research Center

 

 

 

John Bartlett, Ph.D., Group Leader, Endocrine Cancer Group, University of Edinburgh Cancer Research Centre

 

 

 

Holly K. Dressman, Ph.D., Associate Research Professor, Director, Duke Microarray Facility